Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Priapism in Sickle Cell Anemia
source: Family Practice Notebook
year: 2018
summary/abstract:Priapism in Sickle Cell Anemia:
II. Epidemiology
Incidence of Priapism in Sickle Cell Anemia: 89% by age 20 years old
III. Management
Duration: Analgesics
IV Fluids
Do not transfuse for Priapism 4 hours
Administer above measures if not already attempted
Exchange transfusion (Risk of CVA symptoms)
Epidural Anesthesia
+myBinderRelated Content
-
Risk factor analysis of cerebral white matter hyperintensities in children with sickle cell diseaseSickle cell disease (SCD) is complicated...
-
Increased incidence of VTE in sickle cell disease patients: risk factors, recurrence and impact on mortalityPrevious reports show increased incidenc...
-
Providing Expert Care for Pregnant Sickle Cell Patienthttps://www.youtube.com/watch?v=rTebitxq...
-
Study challenges view that sickle cell trait increases mortality riskSurprising findings from a study of heal...
-
SCD Patients Benefit From Early Rivipansel Treatment for VOCs, New Analyses ShowStarting treatment with rivipansel (GMI-...
-
The Ways I Made Hydration a HabitWhen I was younger and didn’t have a f...
-
Acute Chest Syndrome – A HRSA EMBRACE Projecthttps://www.youtube.com/watch?v=wRzTQfhG...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.